期刊文献+

联合左心房部分切除治疗局部晚期肺癌在临床中的应用 被引量:1

Pulmonary resection combined with partial resection of left atrium in the treatment of locally advanced lung cancer
下载PDF
导出
摘要 目的探讨心包内肺及部分左心房切除治疗肺癌的手术指征和手术操作要点。方法回顾性分析2004年8月~2009年5月9例晚期肺癌行心包内肺切除合并部分左心房切除患者的临床资料。结果全组无手术死亡,一年生存率为88.9%,最长生存56个月。结论对局部晚期肺癌行肺切除合并左心房部分切除能延长患者生存期,提高患者生活质量。 Objective To discuss the indications of surgical treatment for lung cancer with lung and partial left atrium resection. Methods Nine cases of lung cancer accepted lung and partial left artium resection from Aug 2004 to May 2009 were reviewed. Results There was no Perioperative death, the one year survival rate was 88.9% and the longest survival period after operation was 56 months up today. Conclusion Lung and partial left atrium resection in the surgery treatment of lung cancer can remarkably increase the postoperative survival period and improve the quality of life of the patient.
机构地区 南阳胸科医院
出处 《中外医学研究》 2011年第32期14-15,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 肺癌 外科手术 左心房 Lung cancer Surgical operation Left atrium.
  • 相关文献

参考文献7

  • 1Tsuchiya R. Extended resection of the left atrium great vessels or both for lung cancer. Ann Thorac Surg, 1994,57 (4) :960 -964.
  • 2周清华,刘伦旭,杨俊杰,张卫红,霍永江,杨振华.肺及部分左心房切除术治疗中心型肺癌[J].中华胸心血管外科杂志,1997,13(1):34-36. 被引量:69
  • 3Ruckdeschel JC, Piontadosi S. Ouality of life in lung cancer sur- gical adjuvant trials. Chest, 1994,106 ( Suppl ) :324 - 328.
  • 4Kanth N. Enhancement of thoracic masses using nonionic MR contrast agents. J Comput Assist To mogr, 1994 (18 ) :27 -33.
  • 5Stiglbauer R. Contrast - enhanced MRI for the staging of bron- chogenic carcinoma: comparision with CT and histopathologic staging - preliminary resuhs. Clin Radiol, 1991 (44) :293 - 298,.
  • 6吴一龙.非小细胞肺癌的术前术后综合治疗[J].中国肺癌杂志,2000,3(6):415-418. 被引量:17
  • 7邢洛红,马红云.肺癌患者术后护理体会[J].中国医学创新,2010,7(25):148-149. 被引量:22

二级参考文献20

  • 1吴清美,汪俊美.肺癌患者术后护理[J].浙江临床医学,2007,9(7):1004-1004. 被引量:2
  • 2[1]De Pierre A. Overview of the role for neoadjuvant therapy for early-stage non-small cell lung cancer. Lung Cancer,2000,29(Suppl 2)∶124-125.
  • 3[2]Albain KS, Pass HI. Induction therapy before surgery for non-small cell lung cancer. Lung Cancer,2000,29(Suppl 2)∶168-171.
  • 4[3]De Pierre A, Milleron B, Chevret S, et al. French phase Ⅲ trial of preoperative chemotherapy (PCT) in resectable stage Ⅰ (except T1N0), Ⅱ, Ⅲa non-small cell lung cancer (NSCLC). Lung Cancer,2000,29(Suppl 1)∶91.
  • 5[4]Splinter T, Groen H, Smit E, et al. Randomized multicenter phase Ⅱ study of chemotherapy followed by surgery versus surgery alone in stage Ⅰand Ⅱ non-small cell lung cancer (NSCLC). Lung Cancer,2000,29(Suppl 1)∶90.
  • 6[5]Eberhardt W, Korfee S, Wagner H, et al. "Minimal N2-disease”(operable) stage ⅢA non-small cell lung cancer: Prospectively randomized multicenter German phase-Ⅲ-trial of surgery (S) followed by adjuvant radiotherapy (RTx) versus "Trimodality treatment”-Early results of feasibility and toxicity in this setting. Lung Cancer,2000,29(Suppl 1)∶95-96.
  • 7[6]Mattson K, Ten Valde G, Krofta K, et al. Early results of an international phase Ⅲ study evaluating Taxotere as neo-adjuvant therapy for radically-treatable stage Ⅲ NSCLC. Lung Cancer,2000,29(Suppl 1)∶90.
  • 8[7]O'Rourke N, Armour A. Neo-adjuvant chemotherapy in stage Ⅲ NSCLC in the West of Scotland improves the potential for cure. Lung Cancer,2000,29(Suppl 1)∶107.
  • 9[8]Saito Y, Minami K, Kobayashi M, et al. Ten years' experience of induction therapy for locally advanced NSCLC; a single institution study. Lung Cancer,2000,29(Suppl 1)∶89-90.
  • 10[9]Abolhoda A, Martin J, Ginsberg RJ, et al. Morbidity and mortality for pulmonary resections in lung cancer after induction treatment. Lung Cancer,2000,29(Suppl 1)∶89.

共引文献101

同被引文献9

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部